Medicamen Organics Limited — Updates, 03-06-2025: Press Release

Medicamen Organics has announced a board meeting on the financial results for the quarter and half-year. FY25 revenue jumped 51% YoY to ₹38.19 Cr, led by exports to Africa, CIS, and Southeast Asia. H2 PAT doubled with margins improving to 11.76%. Net Worth nearly doubled to ₹30.48 Cr. Expansion into cosmetics and personal care via subsidiary Grande Etiole adds 84 products, enhancing diversification. Strong international presence across 13 countries supports steady growth and reduces market concentration risks.